Publication:
General characteristics of male breast cancer patients in Bursa region

dc.contributor.authorAvcı, Nilüfer
dc.contributor.authorBalcı, Mehmet Ali
dc.contributor.authorEsen, İrfan
dc.contributor.authorTandoğan, Gülen
dc.contributor.authorMerter, Mustafa
dc.contributor.authorÇubukcu, Erdem
dc.contributor.authorÖlmez, Fatih
dc.contributor.authorCoşkun, Belkıs Nihan
dc.contributor.authorHartavi, Mustafa
dc.contributor.authorTolunay, Şahsine
dc.contributor.buuauthorAvcı, Nilüfer
dc.contributor.buuauthorBalcı, Mehmet Ali
dc.contributor.buuauthorEsen, İrfan
dc.contributor.buuauthorTandoğan, Gülen
dc.contributor.buuauthorMerter, Mustafa
dc.contributor.buuauthorÇUBUKÇU, ERDEM
dc.contributor.buuauthorÖlmez, Fatih
dc.contributor.buuauthorCOŞKUN, BELKIS NİHAN
dc.contributor.buuauthorHartavi, Mustafa
dc.contributor.buuauthorTOLUNAY, ŞAHSİNE
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentMedikal Onkoloji Ana Bilim Dalı
dc.contributor.orcid0000-0003-1465-7153
dc.contributor.researcheridAAI-1612-2021
dc.contributor.researcheridABD-7124-2020
dc.contributor.researcheridAAG-7155-2021
dc.contributor.researcheridABI-4413-2020
dc.contributor.researcheridCCT-7946-2022
dc.contributor.researcheridDYT-8587-2022
dc.contributor.researcheridDFP-9003-2022
dc.contributor.researcheridJGT-4101-2023
dc.contributor.researcheridJGV-7746-2023
dc.contributor.researcheridCUI-5353-2022
dc.date.accessioned2024-10-22T08:08:10Z
dc.date.available2024-10-22T08:08:10Z
dc.date.issued2012-07-01
dc.description.abstractIntroduction: Male breast cancer constitutes less than 1% of all cases of breast cancer. In this study, we analyzed clinical and pathological features of male breast cancer cases, which had been followed up and treated at our institution.Material and Method: The data regarding the main clinicopathological features of the male breast cancer patients were retrieved from the patients' records retrospectively.Results: A total of 16 patients were included in the analysis with a median age of 60 (41-75). The most common cell type was infiltrating ductal carcinoma, comprising 81.3 % of all cases. Most patients were staged as locally advanced (50% - stage 3) at the time of diagnosis. Estrogen and/or progesterone receptor positivity were found in 13 patients (81.3%). HER2 status could be examined in 9 patients, and 4 patients (25%) found to be positive for HER2 overexpression. Overall survival was 3(1-12) years and disease-free survival was 2 (1-8) years.Discussion: Despite the increasing knowledge about breast cancer in women, little is known in case of male breast cancer management. Therefore, there is a strong need to perform randomized studies for the treatment of male breast cancer.
dc.identifier.endpage129
dc.identifier.issn2149-1976
dc.identifier.issue3
dc.identifier.startpage126
dc.identifier.urihttps://hdl.handle.net/11452/46830
dc.identifier.volume8
dc.identifier.wos000218549700004
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherAves
dc.relation.journalJournal of Breast Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBreast cancer
dc.subjectMale
dc.subjectReproductive biology
dc.titleGeneral characteristics of male breast cancer patients in Bursa region
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Medikal Onkoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Patoloji Ana Bilim Dalı
relation.isAuthorOfPublicationf971677f-09c5-4463-bf01-3c6341fbe5f7
relation.isAuthorOfPublicationfaabfe30-a620-4cbe-8b6d-3db71b10ce0e
relation.isAuthorOfPublication13dc6562-e9fe-42fa-8973-dcd80444844e
relation.isAuthorOfPublication.latestForDiscoveryf971677f-09c5-4463-bf01-3c6341fbe5f7

Files

Collections